According to the deployment of the National Medium- and Long-Term Scientific and Technological Development Plan (2006-2020), the State Council organized and implemented a major science and technology major project for the creation of major new drugs. The first batch of declarations has been completed. Beijing Pharmaceutical Group, North China Pharmaceutical Co., Ltd., Shimao Group Co., Ltd., Zhejiang Pharmaceutical Group, Tianjin Tianshili Group, and Jiangsu Hengrui Pharmaceutical Co., Ltd. and other well-known pharmaceutical companies have become “incubators for new drug companiesâ€; In the "Technical Innovation" and "Innovative Drug Research and Development" projects, Beijing Pharmaceutical Group, Tong Ren Tang Group and Beijing Shuanglu Pharmaceutical Co. Automobile aluminum foil covered sound insulation and heat insulation interior trim series Sound Absorbing Material,Building Sound-Absorbing Cotton Material,Heat Insulation For Interior Decoration,Light Weigh Cotton Sound Absorbing Yidebao Technology Development Co.,Ltd. , https://www.zgyidebao.com
"Major new drug creation" is a large-scale science and technology program in China. Through the implementation of special projects, it will develop a group of new drugs with independent intellectual property rights and market competitiveness, and establish a number of technological platforms with advanced levels to form a support for the independent development of China's pharmaceutical industry. New drug innovation capabilities and technology systems. During the “Eleventh Five-Year Plan†period, special projects were started in two batches. The first batch of special projects launched in 2008 included the launching of all projects for the "pharmaculo-species technical transformation" project, some of which initiated the topic of "innovative drug research and development", the "innovative drug research and development technology platform," and "the establishment of a new enterprise drug incubation base." 3 items. The second batch will be launched in 2009. Specifically, the project will start the “Key Technology Research and Development of New Drugs†project, and part of the “innovative drug research and developmentâ€, “innovative drug research and development technology platform†and “innovation drug incubator base construction†"3 items.
At present, the application for the second batch of "major new drug creation" projects has begun.
Several well-known pharmaceutical companies have been selected for the creation of major new drugs